Cargando…
Deferasirox/hydroxychloroquine: Various toxicities and off-label use in coronavirus disease 2019: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050472/ http://dx.doi.org/10.1007/s40278-021-94219-8 |
Ejemplares similares
-
Hydroxychloroquine: Various toxicities secondary to off label use: 3 case reports
Publicado: (2020) -
Hydroxychloroquine/oseltamivir: Various toxicity following off label therapy: case report
Publicado: (2020) -
Chloroquine/hydroxychloroquine: Various toxicities following off label use: 3 case reports
Publicado: (2021) -
Baricitinib/hydroxychloroquine: Various toxicities secondary to off-label use: 4 case reports
Publicado: (2021) -
Hydroxychloroquine: Cardiac toxicity following off-label use: case report
Publicado: (2021)